22-29792435-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032204.5(ASCC2):āc.2020A>Cā(p.Lys674Gln) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00019 in 1,613,890 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032204.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASCC2 | NM_032204.5 | c.2020A>C | p.Lys674Gln | missense_variant, splice_region_variant | 18/20 | ENST00000307790.8 | NP_115580.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASCC2 | ENST00000307790.8 | c.2020A>C | p.Lys674Gln | missense_variant, splice_region_variant | 18/20 | 1 | NM_032204.5 | ENSP00000305502.3 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000207 AC: 52AN: 251420Hom.: 0 AF XY: 0.000213 AC XY: 29AN XY: 135876
GnomAD4 exome AF: 0.000191 AC: 279AN: 1461590Hom.: 1 Cov.: 31 AF XY: 0.000188 AC XY: 137AN XY: 727122
GnomAD4 genome AF: 0.000177 AC: 27AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2023 | The c.2020A>C (p.K674Q) alteration is located in exon 18 (coding exon 17) of the ASCC2 gene. This alteration results from a A to C substitution at nucleotide position 2020, causing the lysine (K) at amino acid position 674 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at